Reply to Fernández-Esparrach et al.

Endoscopy 2024; 56(05): 390-391
DOI: 10.1055/a-2252-4183

Letter to the editor

Authors

Mohamed Abdelrahim

¹Department of Gastroenterology, Royal Devon and Exeter Hospital, Exeter, United Kingdom of Great Britain and Northern Ireland
Pradeep Bhandari

²Department of Gastroenterology, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom of Great Britain and Northern Ireland

References
1 Bhandari P, Abdelrahim M, Alkandari AA. et al. Predictors of long-term outcomes of endoscopic submucosal dissection of early gastric neoplasia in the West: a multicenter study. Endoscopy 2023; 55: 898-906
2 Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018. 5th edn. Gastric Cancer 2021; 24: 1-21
3 Takizawa K, Ono H, Hasuike N. Gastrointestinal Endoscopy Group (GIESG) and the Stomach Cancer Study Group (SCSG) of Japan Clinical Oncology Group. et al. A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010). Gastric Cancer 2021; 24: 479-491
4 Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer 2023; 26: 1-25